DATALEX PLC (DLE.I) Fundamental Analysis & Valuation

DUB:DLE • IE0000527006

Current stock price

0.3 EUR
0 (0%)
Last:

This DLE.I fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. DLE.I Profitability Analysis

1.1 Basic Checks

  • DLE had negative earnings in the past year.
  • DLE had a negative operating cash flow in the past year.
  • In the past 5 years DLE always reported negative net income.
  • In multiple years DLE reported negative operating cash flow during the last 5 years.
DLE.I Yearly Net Income VS EBIT VS OCF VS FCFDLE.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20M -40M

1.2 Ratios

  • With a Return On Assets value of -55.92%, DLE is not doing good in the industry: 88.57% of the companies in the same industry are doing better.
  • Looking at the Return On Equity, with a value of -7410.14%, DLE is doing worse than 88.57% of the companies in the same industry.
Industry RankSector Rank
ROA -55.92%
ROE -7410.14%
ROIC N/A
ROA(3y)-58.08%
ROA(5y)-45.66%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DLE.I Yearly ROA, ROE, ROICDLE.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2K -4K -6K

1.3 Margins

  • Looking at the Gross Margin, with a value of 37.05%, DLE is doing worse than 76.19% of the companies in the same industry.
  • DLE's Gross Margin has improved in the last couple of years.
  • DLE does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 37.05%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.24%
GM growth 5Y2.81%
DLE.I Yearly Profit, Operating, Gross MarginsDLE.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. DLE.I Health Analysis

2.1 Basic Checks

  • DLE does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • DLE has more shares outstanding than it did 1 year ago.
  • DLE has more shares outstanding than it did 5 years ago.
  • The debt/assets ratio for DLE has been reduced compared to a year ago.
DLE.I Yearly Shares OutstandingDLE.I Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
DLE.I Yearly Total Debt VS Total AssetsDLE.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of 1.17, we must say that DLE is in the distress zone and has some risk of bankruptcy.
  • With a Altman-Z score value of 1.17, DLE is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
  • A Debt/Equity ratio of 3.09 is on the high side and indicates that DLE has dependencies on debt financing.
  • DLE has a worse Debt to Equity ratio (3.09) than 85.71% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.09
Debt/FCF N/A
Altman-Z 1.17
ROIC/WACCN/A
WACC13.15%
DLE.I Yearly LT Debt VS Equity VS FCFDLE.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

  • DLE has a Current Ratio of 1.09. This is a normal value and indicates that DLE is financially healthy and should not expect problems in meeting its short term obligations.
  • With a Current ratio value of 1.09, DLE perfoms like the industry average, outperforming 40.95% of the companies in the same industry.
  • DLE has a Quick Ratio of 1.09. This is a normal value and indicates that DLE is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.09, DLE is in line with its industry, outperforming 42.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
DLE.I Yearly Current Assets VS Current LiabilitesDLE.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. DLE.I Growth Analysis

3.1 Past

  • DLE shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.15%.
  • DLE shows a decrease in Revenue. In the last year, the revenue decreased by -4.86%.
  • DLE shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.45% yearly.
EPS 1Y (TTM)-5.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.44%
Revenue 1Y (TTM)-4.86%
Revenue growth 3Y2.56%
Revenue growth 5Y-9.45%
Sales Q2Q%-10.91%

3.2 Future

  • DLE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 36.20% yearly.
  • DLE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.68% yearly.
EPS Next Y69.57%
EPS Next 2Y36.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.38%
Revenue Next 2Y7.68%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
DLE.I Yearly Revenue VS EstimatesDLE.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M
DLE.I Yearly EPS VS EstimatesDLE.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.05 -0.05 0.1

More info and screens

Find the best growth stocksShow best growing peers

1

4. DLE.I Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for DLE. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for DLE. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DLE.I Price Earnings VS Forward Price EarningsDLE.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DLE.I Per share dataDLE.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

  • DLE's earnings are expected to grow with 36.20% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y36.2%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DLE.I Dividend Analysis

5.1 Amount

  • DLE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

DLE.I Fundamentals: All Metrics, Ratios and Statistics

DATALEX PLC

DUB:DLE (9/11/2025, 7:00:00 PM)

0.3

0 (0%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)07-30
Earnings (Next)N/A
Inst Owners4.17%
Inst Owner ChangeN/A
Ins Owners13.16%
Ins Owner ChangeN/A
Market Cap56.45M
Revenue(TTM)27.48M
Net Income(TTM)-10.23M
Analysts45.71
Price Target0.56 (86.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)15.79%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)2.39%
Revenue NY rev (3m)-5.44%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 2.41
P/FCF N/A
P/OCF N/A
P/B 480.03
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.06
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.03
FCFYN/A
OCF(TTM)-0.02
OCFYN/A
SpS0.12
BVpS0
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -55.92%
ROE -7410.14%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 37.05%
FCFM N/A
ROA(3y)-58.08%
ROA(5y)-45.66%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.24%
GM growth 5Y2.81%
F-Score5
Asset Turnover1.5
Health
Industry RankSector Rank
Debt/Equity 3.09
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 52.88%
Cap/Sales 4.78%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 1.17
F-Score5
WACC13.15%
ROIC/WACCN/A
Cap/Depr(3y)81.09%
Cap/Depr(5y)97.95%
Cap/Sales(3y)6.85%
Cap/Sales(5y)7.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-5.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-19.44%
EPS Next Y69.57%
EPS Next 2Y36.2%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.86%
Revenue growth 3Y2.56%
Revenue growth 5Y-9.45%
Sales Q2Q%-10.91%
Revenue Next Year6.38%
Revenue Next 2Y7.68%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-13.83%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year94.61%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y24.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y27.95%
OCF growth 3YN/A
OCF growth 5YN/A

DATALEX PLC / DLE.I Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DATALEX PLC?

ChartMill assigns a fundamental rating of 2 / 10 to DLE.I.


What is the valuation status for DLE stock?

ChartMill assigns a valuation rating of 1 / 10 to DATALEX PLC (DLE.I). This can be considered as Overvalued.


How profitable is DATALEX PLC (DLE.I) stock?

DATALEX PLC (DLE.I) has a profitability rating of 1 / 10.


What is the expected EPS growth for DATALEX PLC (DLE.I) stock?

The Earnings per Share (EPS) of DATALEX PLC (DLE.I) is expected to grow by 69.57% in the next year.